Evaxion A/S (EVAX) Earnings Date & Reports

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVAX is expected to report earnings to fall 94.97% to -17 cents per share on April 02

Q4'23

Est.

$-0.17

Q4'24

Missed

by $2.84

Q3'23

Missed

by $0.02

Q2'23

Beat

by $0.01

Q1'23

Beat

by $0.02

The last earnings report on April 01 showed earnings per share of -338 cents, missing the estimate of -54 cents. With 81.03K shares outstanding, the current market capitalization sits at 16.61M.

View a ticker or compare two or three

Compare

EVAX